SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Sclerosteosis is an autosomal recessive disease that is characterized by overgrowth of bone tissue and is linked to mutations in the gene encoding the secreted protein SOST. Sclerosteosis shares remarkable similarities with "high bone mass" diseases caused by "gain-of-function" mutations in the LRP5 gene, which encodes a coreceptor for Wnt signaling proteins. We show here that SOST antagonizes Wnt signaling in Xenopus embryos and mammalian cells by binding to the extracellular domain of the Wnt coreceptors LRP5 and LRP6 and disrupting Wnt-induced Frizzled-LRP complex formation. Our findings suggest that SOST is an antagonist for Wnt signaling and that the loss of SOST function likely leads to the hyperactivation of Wnt signaling that underlies bone overgrowth seen in sclerosteosis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The SOST protein can also bind to LRP5/6 where it can antagonize Wnt signaling.25”
From Wnt signal transduction pathways (2008) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998) · Nature · doi:10.1038/34848 · Cited by 1,608
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Little, R. D., Folz, C., Manning, S. P., Swain, P. M., Zhao, S.-C., Eustace, B., Lappe, M. M., Spitzer, L., Zweier, S., Braunschweiger, K., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338450 · Cited by 1,282
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
LDL-receptor-related proteins in Wnt signal transduction
Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., Hess, F., Saint-Jeannet, J.-P., & He, X. (2000) · Nature · doi:10.1038/35035117 · Cited by 1,128
Self-citationOsteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,112
An LDL-receptor-related protein mediates Wnt signalling in mice
Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J., & Skarnes, W. C. (2000) · Nature · doi:10.1038/35035124 · Cited by 1,086
Cited by
Items 501–600 of 859
Wnt antagonist as therapeutic targets in ovarian cancer
Narayanaa, Y. K., Perumalsamy, N. K., Warrier, S. R., Perumalsamy, L. R., & Dharmarajan, A. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106191 · Cited by 16
Bone: A Neglected Endocrine Organ?
Szeliga, A., Grymowicz, M., Kostrzak, A., Smolarczyk, R., Bala, G., Smolarczyk, K., Męczekalski, B., & Suchta, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133889 · Cited by 16
Tripathi, A. K., Sardar, A., Rai, N., Rai, D., Girme, A., Sinha, S., Chutani, K., Hingorani, L., Mishra, P. R., & Trivedi, R. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00356 · Cited by 16
Sclerostin promotes human dental pulp cells senescence
Ou, Y., Zhou, Y., Liang, S., & Wang, Y. (2018) · PeerJ · doi:10.7717/peerj.5808 · Cited by 16
The Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research
Sun, M., Chen, Z., Wu, X., Yu, Y., Wang, L., Lü, A., Zhang, G., & Li, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.602330 · Cited by 16
Boschert, V., Frisch, C. M., Back, J. W., van Pee, K., Weidauer, S. E., Muth, E.-M., Schmieder, P., Beerbaum, M., Knappik, A., Timmerman, P., et al. (2016) · Open Biology · doi:10.1098/rsob.160120 · Cited by 16
Morse, A., McDonald, M. M., Schindeler, A., Peacock, L., Mikulec, K., Cheng, T. L., Liu, M., Ke, H. Z., & Little, D. G. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0275-2 · Cited by 16
Liu, S., Luo, Z., Ji, G.-M., Guo, W., Cai, J., Fu, L., Zhou, J., Hu, Y., & Shen, X. (2019) · Molecules · doi:10.3390/molecules24020271 · Cited by 16
Antagonists of LRP6 regulate PTH‐induced cAMP generation
Shi, C., Li, J., Wang, W., Cao, W., Cao, X., & Wan, M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06226.x · Cited by 16
Hormones and Disorders of Mineral Metabolism
Bringhurst, F. R., Demay, M. B., & Kronenberg, H. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00028-9 · Cited by 16
Rentsch, C. A., Cecchini, M. G., & Thalmann, G. N. (2009) · Swiss Medical Weekly · doi:10.4414/smw.2009.12284 · Cited by 16
Alonso, N., & Ralston, S. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11235-8 · Cited by 16
An updated overview of the search for biomarkers of osteoporosis based on human proteomics
Wang, X., Zhang, R.-Z., Wang, Y., Pan, S., Yun, S., Li, J., & Xu, Y. (2024) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.08.015 · Cited by 15
Murine Animal Models in Osteogenesis Imperfecta: The Quest for Improving the Quality of Life
Alcorta-Sevillano, N., Infante, A., Macías, I., & Rodríguez, C. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010184 · Cited by 15
Scope of Wnt signaling in the precise diagnosis and treatment of breast cancer
Patel, D. K., Kesharwani, R., Verma, A., Al-Abbasi, F. A., Anwar, F., & Kumar, V. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103597 · Cited by 15
Brogi, S., Maramai, S., Brindisi, M., Chemi, G., Porcari, V., Corallo, C., Gennari, L., Novellino, E., Ramunno, A., Butini, S., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700551 · Cited by 15
Yamaguchi, Y., Kumagai, K., Imai, S., Miyatake, K., & Saito, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201839 · Cited by 15
Mice Carrying a Ubiquitous R235W Mutation of Wnt1 Display a Bone-Specific Phenotype
Yorgan, T. A., Rolvien, T., Stürznickel, J., Vollersen, N., Lange, F., Zhao, W., Baranowsky, A., Rosenthal, L., Hermans-Borgmeyer, I., Sharaf, A. L., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4043 · Cited by 15
Pax6 Expressed in Osteocytes Inhibits Canonical Wnt Signaling
Jami, A., Gadi, J., Lee, M. J., Kim, E. J., Lee, M. J., Jung, H.-S., Kim, H., & Lim, S.-K. (2013) · Molecules and Cells · doi:10.1007/s10059-013-2310-0 · Cited by 15
Sclerostin is essential for alveolar bone loss in occlusal hypofunction
Xu, Y., Wang, L., Sun, Y., Han, X., Gao, T., Xu, X., Tian, C., Zhao, X., Zeng, H., WANG, Y., et al. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3124 · Cited by 15
The Skeletal Subsystem as an Integrative Physiology Paradigm
Weiss, A., Iqbal, J. Z., Zaidi, N., & Mechanick, J. I. (2010) · Current Osteoporosis Reports · doi:10.1007/s11914-010-0033-0 · Cited by 15
Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy
Laster, M. L., Pereira, R. C., Noche, K. J., Gales, B., Salusky, I. B., & Albrecht, L. V. (2023) · Nutrients · doi:10.3390/nu15194127 · Cited by 14
Lin, C., Yang, Y.-S., Ma, H., Chen, Z., Chen, D., John, A. A., Xie, J., Gao, G., & Shim, J. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.06.036 · Cited by 14
Effects of mild hyperbaric oxygen on osteoporosis induced by hindlimb unloading in rats
Takemura, A., Pajevic, P. D., Egawa, T., Teshigawara, R., Hayashi, T., & Ishihara, A. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01100-6 · Cited by 14
Genetics and Genomics of SOST: Functional Analysis of Variants and Genomic Regulation in Osteoblasts
Martínez‐Gil, N., Roca‐Ayats, N., Cozar, M., García‐Giralt, N., Ovejero, D., Nogués, X., Grinberg, D., & Balcells, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020489 · Cited by 14
The role of sclerostin in lipid and glucose metabolism disorders
Jiang, H., Li, D., Han, Y., Li, N., Tao, X., Liu, J., Zhang, Z., Yu, Y., Wang, L., Yu, S., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115694 · Cited by 13
Miyatake, K., Kumagai, K., Imai, S., Yamaguchi, Y., & Inaba, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239651 · Cited by 13
Sclerostin and its role as a bone modifying agent in periodontal disease
Ashifa, N., Viswanathan, K., Sundaram, R., & Srinivasan, S. (2021) · Journal of Oral Biosciences · doi:10.1016/j.job.2021.04.002 · Cited by 13
All the might of the osteocyte: emerging roles in chronic kidney disease
Albrecht, L. V., Pereira, R. C., & Salusky, I. B. (2023) · Kidney International · doi:10.1016/j.kint.2023.08.009 · Cited by 13
Morales, S., Díez‐Pérez, A., Olmos, J. M., Nogués, X., Henríquez, M. S., Díaz Curiel, M., Pérez‐Castrillón, J. L., Pérez-Cano, R., Torrijos, A., Jódar, E., et al. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.08.007 · Cited by 13
van Bezooijen, R. L., Papapoulos, S. E., Hamdy, N. A. T., ten Dijke, P., & Löwik, C. W. G. M. (2005) · BoneKEy-Osteovision · doi:10.1138/20050189 · Cited by 13
Lu, T., Forgetta, V., Zhou, S., Richards, J. B., & Greenwood, C. M. T. (2023) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4920 · Cited by 12
Targeting WNT signalling pathways as new therapeutic strategies for osteoarthritis
Iqbal, Z., Xia, J., Murtaza, G., Shabbir, M., Rehman, K., Yujie, L., & Duan, L. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2281861 · Cited by 12
Thouverey, C., Apostolides, P., Brun, J., Caverzasio, J., & Ferrari, S. (2024) · JCI Insight · doi:10.1172/jci.insight.176558 · Cited by 12
Osteoarthritis - Progress in Basic Research and Treatment
Chen, Q. (2015) · InTech eBooks · doi:10.5772/58640 · Cited by 12
Wang, L., Wu, H., Xu, Y., Deng, M., Han, X.-L., & Bai, D. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1077323 · Cited by 12
Bariatric Surgery and Bone Loss: Do We Need to Be Concerned?
Brzozowska, M. M., Sainsbury, A., Eisman, J. A., & Baldock, P. A. J. (2014) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-014-9162-9 · Cited by 12
Strollo, R., Soare, A., Khazrai, Y. M., Mauro, A. D., Palermo, A., Toro, R. D., Fallucca, S., Belluomo, M. G., Dugo, L., Pianesi, M., et al. (2016) · Endocrine · doi:10.1007/s12020-016-1171-7 · Cited by 12
Manipulating the Plasticity of Smooth Muscle Cells to Regulate Vascular Calcification
McArthur, K. M., Kay, A. M., Mosier, J. A., Grant, J. N., Stewart, J. A., & Simpson, C. L. (2017) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2017.3.165 · Cited by 12
Primary Cilia-Mediated Mechanotransduction in Bone
Lee, K. L., Hoey, D. A., & Jacobs, C. R. (2010) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-010-9078-y · Cited by 12
Song, J., Chang, W., Wang, Y., Gao, P., Zhang, J., Xiao, Z., An, F., & Yan, C. (2024) · Biomolecules and Biomedicine · doi:10.17305/bb.2024.11200 · Cited by 11
The systemic effects of sclerostin overexpression using ΦC31 integrase in mice
Zhang, D., Park, B. M., Kang, M., Nam, H. J., Kim, E. J., Bae, C. H., & Lim, S. K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.178 · Cited by 11
Relevance of Wnt signaling for osteoanabolic therapy
Yorgan, T. A., & Schinke, T. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-22 · Cited by 11
Sclerosteosis caused by a novel nonsense mutation of SOST in a consanguineous family
He, W., Chen, C., Pan, C., Zhang, M., Yu, X., Wang, D. W., & Hu, S. (2015) · Clinical Genetics · doi:10.1111/cge.12655 · Cited by 11
Differential Expression of Sclerostin in Adult and Juvenile Mouse Calvariae
Kwan, M. D., Quarto, N., Gupta, D. M., Slater, B. J., Wan, D. C., & Longaker, M. T. (2011) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181fed60d · Cited by 11
Loss of mechanosensitive sclerostin may accelerate cranial bone growth and regeneration
Kang, K. S., Lastfogel, J., Ackerman, L. L., Jea, A. H., Robling, A. G., & Tholpady, S. S. (2017) · Journal of neurosurgery · doi:10.3171/2017.5.jns17219 · Cited by 11
Coupling: The Influences of Immune and Bone Cells
Sims, N., Martin, T., & Quinn, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00010-4 · Cited by 8
Kragl, A., Schoon, J., Tzvetkova, A., Wenzel, C., Blaschke, M., Böcker, W., Siggelkow, H., & Tzvetkov, M. V. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.953034 · Cited by 10
Examining Mechanisms for Voltage-Sensitive Calcium Channel-Mediated Secretion Events in Bone Cells
Fernandez, P. C. R., Wright, C. S., Farach‐Carson, M. C., & Thompson, W. R. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01097-w · Cited by 10
Yu, S., Huang, W., Zhang, H., Guo, Y., Zhang, B., Zhang, G., & Lei, J. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116414 · Cited by 10
Li, M., Li, S., Liu, J. F., Cui, X., Zhang, S., Zhou, J., Wang, X., & Yao, Q. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36704 · Cited by 10
Circulating bioactive sclerostin levels in an Austrian population-based cohort
Kerschan‐Schindl, K., Föger‐Samwald, U., Gleiß, A., Kudlacek, S., Wallwitz, J., & Pietschmann, P. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-021-01815-0 · Cited by 10
Dai, Z., Fang, P., Yan, X., Zhu, R., Feng, Q., Yan, Q., Yang, L., Fan, X., Xie, Y., Zhuang, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.770073 · Cited by 10
Zhong, Z. A., & Williams, B. O. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1715 · Cited by 10
Role of Wnt-p53-Nox Signaling Pathway in Cancer Development and Progression
Kumar, D., Sharma, S., Verma, S., Kumar, P., & Ambasta, R. K. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2015/17996 · Cited by 10
Expression of sclerostin in the developing zebrafish (Danio rerio) brain and skeleton
McNulty, M. S., Bedell, V. M., Greenwood, T. M., Craig, T. A., Ekker, S. C., & Kumar, R. (2012) · Gene Expression Patterns · doi:10.1016/j.gep.2012.04.003 · Cited by 10
Bone and Cartilage Regeneration
Fellows, C., Gauthaman, K., Pushparaj, P., Abbas, M., Matta, C., Lewis, R., Buhrmann, C., Shakibaei, M., & Mobasheri, A. (2016) · Stem cells in clinical applications · doi:10.1007/978-3-319-40144-7 · Cited by 10
Zarei, A., Hulley, P. A., Sabokbar, A., & Javaid, M. K. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0246-7 · Cited by 10
Modeling craniofacial and skeletal congenital birth defects to advance therapies
Neben, C. L., Roberts, R. R., Dipple, K. M., Merrill, A. E., & Klein, O. D. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw171 · Cited by 10
Osteoclast Secretes Stage‐Specific Key Molecules for Modulating Osteoclast–Osteoblast Communication
Fu, Y., Shi, S., Wu, J., Yuan, Z., Wang, L. F., Nie, H., Zhang, Z., Wu, X., Chen, Y., Ti, H., et al. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31484 · Cited by 9
Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus
Ross, R. D., Sharma, A., Shi, Q., Hoover, D. R., Weber, K. M., Tien, P. C., French, A. L., Al‐Harthi, L., & Yin, M. T. (2020) · Bone Reports · doi:10.1016/j.bonr.2020.100279 · Cited by 9
Yamamoto, T., Hasegawa, T., de Freitas, P. H. L., Hongo, H., Zhao, S., Yamamoto, T., Nasoori, A., Abe, M., Maruoka, H., Kubota, K., et al. (2021) · Biomedical Research · doi:10.2220/biomedres.42.161 · Cited by 9
Osteoporosis Genes Identified by Genome-Wide Association Studies
Rivadeneira, F., & Uitterlinden, A. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00022-8 · Cited by 9
Novel variants in the LRP4 underlying Cenani-Lenz Syndactyly syndrome
Khan, H., Chong, A. E. Q., Bilal, M., Nawaz, S., Abdullah, Abbasi, S., Hussain, A., Hussain, S., Ullah, I., Ali, H., et al. (2021) · Journal of Human Genetics · doi:10.1038/s10038-021-00995-x · Cited by 9
Biedroń, G., Czepiel, M., Siedlar, M., & Korkosz, M. (2023) · Rheumatology International · doi:10.1007/s00296-023-05452-w · Cited by 9
How rare bone diseases have informed our knowledge of complex diseases
Johnson, M. L. (2016) · BoneKEy Reports · doi:10.1038/bonekey.2016.69 · Cited by 9
Diao, X., Li, Z., An, B., Xin, H., Wu, Y., Li, K., Feng, F., & Dou, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-06867-9 · Cited by 9
Characterization of the different oligomeric states of the DAN family antagonists SOSTDC1 and SOST
Gipson, G. R., Kattamuri, C., Czepnik, M., & Thompson, T. B. (2020) · Biochemical Journal · doi:10.1042/bcj20200552 · Cited by 9
Garnero, P., & Cremers, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00078-6 · Cited by 9
Su, Y., Wang, W., Liu, F., Cai, Y., Li, N., Li, H., Li, G., & Ma, L. (2022) · Annals of Palliative Medicine · doi:10.21037/apm-22-998 · Cited by 9
van Bezooijen, R. L., Papapoulos, S. E., Hamdy, N. A. T., & Löwik, C. W. G. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00014-8 · Cited by 9
Hu, S., Yang, L., Wu, C., & Liu, T.-Y. (2019) · Physiology International · doi:10.1556/2060.106.2019.07 · Cited by 9
Bone and Cartilage Regeneration: Wnt Signaling Pathway in Healing
Thorfve, A. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 9
Huybrechts, Y., Boudin, E., Hendrickx, G., Steenackers, E., Hamdy, N. A. T., Mortier, G. R., Diaz‐Guerra, G. M., Bracamonte, M. S., Appelman‐Dijkstra, N. M., & Hul, W. V. (2021) · Genes · doi:10.3390/genes13010080 · Cited by 8
LRP5 promotes adipose progenitor cell fitness and adipocyte insulin sensitivity
Loh, N. Y., Vasan, S. K., Rosoff, D. B., Roberts, E., van Dam, A. D., Verma, M., Phillips, D., Wesolowska‐Andersen, A., Neville, M. J., Noordam, R., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00774-1 · Cited by 8
The potential use of antisclerostin therapy in chronic kidney disease – mineral and bone disorder
Costa, A. G., Bilezikian, J. P., & Lewiecki, E. M. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000133 · Cited by 8
Kanaya, S., Komatsu, H., Shimauchi, H., & Nemoto, E. (2016) · Connective Tissue Research · doi:10.1080/03008207.2016.1195826 · Cited by 8
Bullock, W. A., & Robling, A. G. (2017) · Toxicologic Pathology · doi:10.1177/0192623317738170 · Cited by 8
Secreted Wnt antagonists in leukemia: A road yet to be paved
Pehlivan, M., Çalışkan, C., Yüce, Z., & Sercan, H. O. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.03.011 · Cited by 8
Wang, H., Zhao, S., Liu, Y., Sun, F., Huang, X., & Wu, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.898047 · Cited by 8
Recent developments in bone anabolic therapy for osteoporosis
Guo, B., Peng, S., Liang, C., He, X., Xiao, C., Lu, C. C., Jiang, M., Zhao, H., Lü, A., & Zhang, G. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.63 · Cited by 8
Self-citationWang, W.-J., Fu, W., He, J.-W., Wang, C., & Zhang, Z. (2018) · The Pharmacogenomics Journal · doi:10.1038/s41397-018-0059-8 · Cited by 8
Samiei, M., Janjić, K., Cvikl, B., Moritz, A., & Agis, H. (2019) · F1000Research · doi:10.12688/f1000research.17801.1 · Cited by 8
Osteocyte mechanosensing following short-term and long-term treatment with sclerostin antibody
Morrell, A. E., Robinson, S. T., Ke, H. Z., Holdsworth, G., & Guo, X. E. (2021) · Bone · doi:10.1016/j.bone.2021.115967 · Cited by 8
Aspects of intercellular communication in bone and implications in therapy
Martin, T. J. (2021) · Bone · doi:10.1016/j.bone.2021.116148 · Cited by 8
Boudin, E., Piters, E., Fransén, E., Nielsen, T. L., Andersen, M., Roef, G. L., Taes, Y., Brixen, K., & Hul, W. V. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.11.189 · Cited by 8
Rat Osteosarcoma Cells as a Therapeutic Target Model for Osteoregeneration via Sclerostin Knockdown
Sedaghati, B., Jahroomishirazi, R., Starke, A., Hacker, M. C., & Schulz‐Siegmund, M. (2016) · Cells Tissues Organs · doi:10.1159/000444634 · Cited by 8
High-Throughput Tool for Discovery of Bone Regulating Factors
Sharma, P., Solomon, K. R., & Hauschka, P. V. (2006) · BioTechniques · doi:10.2144/000112280 · Cited by 8
Wnt Signaling in Periodontal Disease
González‐Quintanilla, D., Abásolo, N., & Astudillo, P. (2021) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2021.763308 · Cited by 7
Dai, Z., Zhu, R., Sheng, Z., Qin, G., Luo, X., Qin, Q., Song, C., Li, L., Jin, P., Yang, G., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1168757 · Cited by 7
Hsieh, F.-L., Chang, T.-H., Gabelli, S. B., & Nathans, J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2217096120 · Cited by 7
D’Souza, D. G., Rana, K., Milley, K. M., MacLean, H. E., Zajac, J. D., Bell, J. D., Brenner, S., Venkatesh, B., Richardson, S. J., & Danks, J. A. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.06.021 · Cited by 7
Vitamin D, Inflammation and Osteoporosis in Rheumatoid Arthritis
Sainaghi, P. P., & Gibbin, A. (2018) · The Open Rheumatology Journal · doi:10.2174/1874312901812010300 · Cited by 7
A novel biallelic splice‐site variant in the LRP4 gene causes sclerosteosis 2
Bukowska‐Olech, E., Sowińska‐Seidler, A., Szczałuba, K., & Jamsheer, A. (2020) · Birth Defects Research · doi:10.1002/bdr2.1676 · Cited by 7
Rubin, J. E., & Rubin, C. T. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0608 · Cited by 7
Wild, J., Pateisky, P., Küssel, L., Huf, W., Ott, J., Haslinger, P., Knöfler, M., & Zeisler, H. (2014) · Hypertension in Pregnancy · doi:10.3109/10641955.2014.880455 · Cited by 7
Yiğit, U., Kırzıoğlu, F. Y., & Özmen, Ö. (2022) · Biotechnic & Histochemistry · doi:10.1080/10520295.2022.2036370 · Cited by 6
Ashifa, N., Viswanathan, K., Srinivasan, S., Kumar, S. P., Sundaram, R., & Pavithran, V. K. (2023) · Journal of Advanced Periodontology & Implant Dentistry · doi:10.34172/japid.2023.009 · Cited by 6
Brunetti, J., Falciani, C., Bernini, A., Scali, S., Bracci, L., & Lozzi, L. (2020) · Amino Acids · doi:10.1007/s00726-020-02860-1 · Cited by 6
Loss of Nmp4 enhances bone gain from sclerostin antibody administration
Korff, C., Adaway, M., Atkinson, E. G., Horan, D. J., Klunk, A. J., Silva, B. S., Bellido, T., Plotkin, L. I., Robling, A. G., & Bidwell, J. P. (2023) · Bone · doi:10.1016/j.bone.2023.116891 · Cited by 6
Metadata
- Authors
- Semënov, M., Tamai, K., & He, X.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- He, Xi
- ORCID
- He, Xi
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 280
- Issue
- 29
- Pages
- 26770-26775
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2002725330
- Cited by
- 771
- References
- 42
- Citations by year
- 2026: 20 · 2025: 9 · 2024: 22 · 2023: 32 · 2022: 32 · 2021: 36 · 2020: 42 · 2019: 29 · 2018: 34 · 2017: 44 · 2016: 50 · 2015: 53 · 2014: 51 · 2013: 51 · 2012: 50
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5555 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- W. M. Keck Foundation
- Uehara Memorial Foundation
- National Institutes of Health
- National Institute of General Medical Sciences (GM057603)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- sclerostin, sclerosteosis, LRP5, LRP6, Wnt signaling, ligand binding, bone overgrowth, high bone mass, gain-of-function mutations, Xenopus embryo
- MeSH terms
- Animals, Bone Diseases, Developmental, Cell Line, Embryo, Mammalian, Embryo, Nonmammalian, Genetic Markers, Humans, Ligands, Protein Binding, Proteins, Receptors, LDL, Transfection, Xenopus, Signal Transduction, Bone Morphogenetic Proteins, Body Patterning, LDL-Receptor Related Proteins, Intercellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Wnt Proteins, Frizzled Receptors, Low Density Lipoprotein Receptor-Related Protein-6, Low Density Lipoprotein Receptor-Related Protein-5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.